碘佛醇、碘克沙醇和碘普罗胺对早期糖尿病肾病患者肾功能的影响

中国药物警戒 ›› 2019, Vol. 16 ›› Issue (4): 199-202.

碘佛醇、碘克沙醇和碘普罗胺对早期糖尿病肾病患者肾功能的影响

王胜奇¹, 汪爱丹²

1首都医科大学宣武医院急诊科,北京 100045;
2首都医科大学宣武医院放射科,北京100045

收稿日期:2019-05-09 修回日期:2019-05-09 出版日期:2019-04-20 发布日期:2019-05-09
通讯作者: 汪爱丹,女,本科,护师,护理学。E-mail:984969491@qq.com
作者简介:王胜奇,男,硕士,主治医师,急诊医学。

Effects of Ioversol, Iodixanol, Iopromide on Renal Function in Patients with Early Diabetic Nephropathy

WANG Shengqi¹, WANG Aidan²

1Emergency Department of Capital Medical University Xuanwu Hospital, Beijing 100045, China;
2Radiology Department of Capital Medical University Xuanwu Hospital, Beijing 100045, China

Received:2019-05-09 Revised:2019-05-09 Online:2019-04-20 Published:2019-05-09

摘要/Abstract

摘要： 目的观察碘佛醇、碘克沙醇和碘普罗胺对早期糖尿病肾病患者肾功能的影响。方法将拟行强化CT检查的163例早期糖尿病肾病患者随机分为碘佛醇组、碘克沙醇组和碘普罗胺组。所有入组患者均在行强化CT检查前及检查后5、10天查血肌酐（Scr）、尿素氮（BUN）及尿微量白蛋白与肌酐比值（mAlb·Cr-1）,计算肾小球滤过率（eGFR）,比较3组肾功能指标变化及造影剂肾病发生率。结果强化CT检查5天后3组患者SCr、BUN及mAlb·Cr-1均较检查前升高（P<0.05）,eGFR较检查前降低（P<0.05）。检查10天后碘佛醇组、碘普罗胺组mAlb·Cr-1、eGFR仍未恢复至检查前水平;强化CT检查5天后碘克沙醇组SCr、mAlb·Cr-1明显低于碘佛醇组（P<0.05）,GRF明显高于碘佛醇组（P<0.05）;碘普罗胺组SCr明显低于碘佛醇组（P<0.05）,GRF明显高于碘佛醇组（P<0.05）。碘佛醇组造影剂肾病（CIN）发生率明显高于碘克沙醇组及碘普罗胺组（P<0.05）,碘普罗胺组CIN发生率明显高于碘克沙醇组（P<0.05）。结论在早期糖尿病肾病患者中选择等渗造影剂可以减低造影剂肾病发生率。在渗透压相同的情况下,造影剂粘度越低的造影剂,造影剂肾病发生率越低。

关键词: 造影剂肾病, 糖尿病肾病, 碘佛醇, 碘克沙醇, 碘普罗胺

Abstract: Objective To observe the effects of ioversol, iodixanol and iopromide on renal function in patients with early diabetic nephropathy. Methods 163 cases of patients with early diabetic nephropathy(DN) that prepare for enhanced CT examination were randomly divided into group ioversol group, iodixanol group and iopromide group. The blood urea nitrogen(BUN), creatinine(Scr) and urinary albumin/creatinine ratio(mAlb·Cr-1) were checked before and 5 days, 10 days after the CT scan. The glomerular filtration rates(eGFR) were calculated. The renal function indexes, incidences of contrast nephropathy were compared. Results The levels of SCr, BUN and mAlb·Cr-1 after 5 days of enhanced CT examination were higher than that before the examination in the 3 groups (P <0.05). The eGFR was lower than that before the examination (P <0.05). The mAlb·Cr-1, eGFR of ioversol group and iopromide group after 10 days of enhanced CT examination did not recover the levels before the examination. The SCr and mAlb·Cr-1 of iodixanol group were significantly lower than that of ioversol group 5 days after CT examination (P <0.05). The eGRF was significantly higher than that of ioversol group (P <0.05). The SCr of iopromide group was significantly lower than that of ioversol group (P <0.05). The eGRF was significantly higher in ioversol group (P <0.05). The incidence of CIN was significantly higher in ioversol group than in iodixanol and iopromide group (P <0.05). The incidence of CIN was significantly higher in iopromide group than in iodixanol group (P <0.05). Conclusion Low-osmolality iodinated contrast media can reduce the incidence of CIN in patients with early DN. If the osmolality is similar, as the viscosity of the contrast media increases, the incidence of contrast nephropathy increases.

Key words: contrast-induced nephropathy, diabetic nephropathy, ioversol, iodixanol, iopromide

中图分类号:

R981

王胜奇, 汪爱丹. 碘佛醇、碘克沙醇和碘普罗胺对早期糖尿病肾病患者肾功能的影响[J]. 中国药物警戒, 2019, 16(4): 199-202.

WANG Shengqi, WANG Aidan. Effects of Ioversol, Iodixanol, Iopromide on Renal Function in Patients with Early Diabetic Nephropathy[J]. Chinese Journal of Pharmacovigilance, 2019, 16(4): 199-202.

参考文献

[1] Deek H, Newton P, Sheerin N, et al.Contrast media induced nephropathy: a literature review of the available evidence and recommendations for practice[J]. Aust CritCare, 2014, 27(4):166-171.
[2] Levy E M, Viscoli C M, Horwitz R I.The effect of acute renal failure on mortality. A cohort analysis[J]. JAMA, 1996, 275(19) : 1489-1494.
[3] Stacul F, Van der Molen A J, Reimer P, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines[J]. Eur Radiol, 2011, 21(12) : 2527-2541.
[4] American Diabetes Association.Standards of medical care in diabetes-2014[J]. Diabetes Care, 2014, 37(Suppl 1): S14-S80.
[5] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2013年版)[J]. 中华糖尿病杂志,2014, 6(7):447-496.
[6] McCullough P A, Sandberg K R. Epidemiology of contrastinduced nephropathy[J]. Rev Cardiovasc Med,2003, 4(Suppl 5): S3-S9.
[7] Talner L B, Davidson A J.Renal hemodynamic effects of contrast media[J]. Invest Radio l,1968, 3(5) : 310-317 .
[8] Weisberg L S, Kurnik P B, Kurnik B R.Radiocontrast-induced nephropathy in humans: Role of renal vasoconstriction[J]. Kidney Int, 1992, 41(5):1408-1415.
[9] Detrenis S, Meschi M, Musini S, et al.Lights and shadows on the pathogenesis of contrast-induced nephropathy: state of the art[J]. Nephrol Dial Transplant, 2005, 20(8):1542-1550.
[10] Hardiek K, Katholi R E, Ramkumar V, et al.Proximal tubule cell response to radiographic contrast media[J]. Am J Physiol Renal Physiol ,2001, 280(1): F61-F70.
[11] Heyman S N, Clark B A, Kaiser N, et al.Radiocontrast agents induce endothelin release in vivo and in vitro[J]. J Am Soc Nephrol, 1992, 3(1):58-65.
[12] Bakris G L, Lass N, Gaber A O, et al.Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals[J]. A m J Physiol, 1990, 258(2) : 115-120.
[13] Parfrey P S, Griffiths S M, Barrett B J, et al.Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study[J]. New Engl J Med,1989, 320(3):143-149.
[14] Toprak O.Risk markers for contrast-induced nephropathy[J]. Am J Med Sci, 2007, 334(4): 283-290.
[15] Rihal C S, Textor S C, Grill D E, et al.Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention[J]. Circuation, 2002, 105(19):2259-2264.
[16] Bader B D, Berger E D, Heede M B, et al.What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?[J]. Clin Nephrol, 2004, 62(1): 1-7.
[17] Bottinor W, Polkampally P, Jovin I.Adverse reactions to iodinated contrast media[J]. International Journal of Angiology, 2013, 22(3): 149-153.
[18] Solomon R.The role of osmolality in the incidence of contrast-induced nephropathy: a systematic review of angiographic contrast media in high risk patients[J]. Kidney Int,2005,68(5): 2256-2263.
[19] Barrett B J, Carlisle E J.Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media[J]. Radiology, 1993, 188(1):171-178.
[20] Pannu N, Wiebe N, Tonelli M.Prophylaxis strategies for contrast-induced nephropathy[J]. JAMA, 2006, 295(23): 2765-2779.